• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Durata Therapeutics Inc

+ Add to Watchlist

DRTX:US

14.4069 USD 0.0769 0.54%

As of 09:51:35 ET on 07/24/2014.

Snapshot for Durata Therapeutics Inc (DRTX)

Open: 14.3300 Day's Range: 14.3000 - 14.4069 Volume: 5,071
Previous Close: 14.3300 52wk Range: 7.7200 - 18.1700 1-Yr Rtn: +80.10%

Stock Chart for DRTX

No chart data available.
  • DRTX:US 14.4300
  • 1D
  • 1M
  • 1Y
14.3300
Interactive DRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.4006
Est. EPS (USD) (12/2014) -2.4260
Est. PEG Ratio -
Market Cap (M USD) 381.78
Shares Outstanding (M) 26.64
30 Day Average Volume 274,350
Price/Book (mrq) 19.6787
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DRTX

Durata Therapeutics, Inc. develops, acquires, and commercializes therapeutics for the treatment of infectious diseases. The Company focuses on antibiotic treatments for acute bacterial skin and skin structure infections for the specialist physician market.

Paul R EdickChief Executive OfficerCorey N FishmanCFO/COO/Treasurer/Secretary
John P ShannonChief Commercial OfficerMichael W DunneChief Medical Officer
More Company Profile & Key Executives for DRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil